Claudia Berger

Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: Results of a Randomized Phase 3 Placebo-Controlled Study (Study 301)

Abstract: Background: Patients with MDD often do not respond to antidepressant (ADT) monotherapy. Cariprazine (CAR) is under investigation as adjunctive therapy for patients with MDD. M...

Cara Lutzow ;

Claudia Berger ;

01/19/2023

Effects of Cariprazine on Reducing Symptoms of Hostility and Agitation in Patients with Manic or Mixed Episodes of Bipolar I Disorder

Abstract: Background: Bipolar mania and mixed episodes can be associated with hostility and agitated behavior. Effects of cariprazine on these symptoms were evaluated in this post hoc ana...

Huy-Binh Nguyen ;

Claudia Berger ;

01/19/2023

Estimating Changes in Weight and Metabolic Parameters Before and After Treatment With Cariprazine: A Retrospective Study of Electronic Health Records

Abstract: Introduction: Effects of cariprazine on weight and metabolic parameters were evaluated. Methods: Analyses based on Optum Humedica electronic health records data from October 1,...

Huy-Binh Nguyen ;

Claudia Berger ;

01/19/2023

The NP Psych Navigator: A Multimedia Website for Nurse Practitioners Who Treat Patients With Mental Health Disorders

Abstract: Background: Psychiatric nurse practitioners (NPs) need access to appropriate, up-to-date educational materials to help them successfully diagnose and clinically manage their pat...

Claudia Berger ;

Tina Matthews-Hayes ;

01/19/2023

Safety and Tolerability of Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: A Pooled Analysis of Phase 2B and 3 Clinical Trials

Abstract: Background: Safety of cariprazine in patients with major depressive disorder (MDD) with inadequate response to antidepressants was evaluated. Methods: Safety, tolerability, and ...

Claudia Berger ;

Marco Viscomi ;

01/19/2023